Invest in ME have now raised £57,000 for their UK rituximab trial from a variety of organisations and individuals and can begin the first phase.
The UCL team is working on a study to confirm and expand Dr Bansal’s B cell results in a different cohort of ME patients. IiME’s advisor, Professor Jonathan Edwards, will be consulting with Norwegian researchers Professor Olav Mella and Dr Oystein Fluge about their trial.
Quick Overview of the IiME/UCL Clinical Trial
Interview with Professor Jonathan Edwards
The £350,000 trial is being funded through the ‘Matrix project’. 100 people or organisations are invited to contribute by pledging to raise or donate £1,000 each.
